These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10328037)

  • 21. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
    Yu H; Karunakaran KP; Jiang X; Brunham RC
    Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards a Chlamydia trachomatis vaccine: how close are we?
    Cochrane M; Armitage CW; O'Meara CP; Beagley KW
    Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
    Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
    Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlamydia trachomatis vaccine research through the years.
    Schautteet K; De Clercq E; Vanrompay D
    Infect Dis Obstet Gynecol; 2011; 2011():963513. PubMed ID: 21747646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serovar distribution of urogenital C trachomatis isolates in Germany.
    Näher H; Petzoldt D
    Genitourin Med; 1991 Apr; 67(2):114-6. PubMed ID: 2032702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetic profile of azithromycin. Role in the treatment of genital Chlamydia infections].
    Chulig I
    Antibiot Khimioter; 1996 Feb; 41(2):14-5. PubMed ID: 8929112
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
    Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
    Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The laboratory diagnosis of urogenital chlamydiosis].
    Delektorskiĭ VV; Iashkova GN; Mazurchuk SA; Galiautdinov ShD
    Klin Lab Diagn; 1995; (6):108-10. PubMed ID: 8589945
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
    Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
    Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of Chlamydia trachomatis in diseases of the urogenital system].
    Török L; Deák J; Scultéty S; Földes J
    Orv Hetil; 1991 May; 132(18):963-6. PubMed ID: 2027668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential for vaccine development against chlamydial infection and disease.
    Brunham RC; Zhang DJ; Yang X; McClarty GM
    J Infect Dis; 2000 Jun; 181 Suppl 3():S538-43. PubMed ID: 10839755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
    Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L
    BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards a Chlamydia vaccine. Interview by Kelly McCauley.
    Igietseme J
    Expert Rev Vaccines; 2004 Jun; 3(3):237-42. PubMed ID: 15176940
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMMUNOLOGY. A Chlamydia vaccine on the horizon.
    Brunham RC
    Science; 2015 Jun; 348(6241):1322-3. PubMed ID: 26089500
    [No Abstract]   [Full Text] [Related]  

  • 36. [Urogenital infections linked to Chlamydia and mycoplasmas].
    Fourmaux S; Bebear C
    Prog Urol; 1997 Feb; 7(1):132-6. PubMed ID: 9116732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urogenital infections produced by Chlamydia trachomatis].
    Vizitiu O
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(3-4):68-76. PubMed ID: 1340265
    [No Abstract]   [Full Text] [Related]  

  • 38. [Complication of Chlamydia trachomatis infection].
    Sülle K
    Orv Hetil; 1992 Mar; 133(13):818. PubMed ID: 1560977
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of urogenital Chlamydia trachomatis infections by cell culture and the polymerase chain reaction using a closed system.
    Ostergaard L; Traulsen J; Birkelund S; Christiansen G
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1057-61. PubMed ID: 1802697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genitourinary chlamydial infection: a reappraisal and hypothesis.
    Morton RS; Kinghorn GR
    Int J STD AIDS; 1999 Dec; 10(12):765-75. PubMed ID: 10639055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.